Mode
Text Size
Log in / Sign up

Narrative review of Digital First Primary Care model in NHS England patientsDigital-first care offers flexibility but gains are uneven for NHS patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that DFPC gains are uneven and emergency evidence differs from routine policy.

This narrative review examines the Digital First Primary Care (DFPC) model within the setting of NHS England. The scope includes secondary outcomes such as convenience, flexibility, timeliness of first contact, and patient-centered care domains including access, autonomy, shared decision-making, continuity, relational quality, and equity. No specific sample size or numerical effect sizes are reported for these outcomes.

Key findings indicate that convenience, flexibility, and timeliness of first contact can improve for some patients. Conversely, the distribution of these gains is described as unevenly distributed across the patient population. The review does not report specific adverse events, discontinuations, or tolerability data.

The authors highlight significant limitations, specifically noting that evidence generated during the COVID-19 emergency should not be conflated with the evaluation of routine, policy-driven post-pandemic DFPC. Practice relevance is framed around the necessity for a flexible hybrid model that preserves modality choice, supports continuity, provides safe escalation to in-person care, and actively mitigates digital exclusion.

Patients in NHS England are looking for care that fits their lives. A new look at the Digital First Primary Care model asks if it delivers on promises of convenience, flexibility, and speed. The review found that these aspects can indeed improve for some patients. This shift allows people to get help faster and on their own schedule when the system supports it.

However, the picture is not the same for everyone. The distribution of these gains is uneven. Some patients see clear benefits in access and autonomy, while others do not. This gap highlights that digital tools alone do not guarantee better care for all groups.

Important context shapes these findings. Evidence from the pandemic emergency should not be mixed with routine policy evaluations. The model only works well when it stays flexible, keeps continuity, and actively helps those who might struggle with digital tools.

What this means for you:
Digital-first care helps some patients but benefits are uneven and depend on flexible implementation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
The Digital First Primary Care (DFPC) model, introduced by NHS England, aims to enhance healthcare accessibility and efficiency by leveraging digital tools such as telemedicine, digital triage, and virtual consultations. In this structured narrative review, we synthesized UK-focused empirical, policy, and implementation literature to examine DFPC through the patient-centered care (PCC) domains of access, autonomy, shared decision-making, continuity, relational quality, and equity. The available evidence suggests that DFPC can improve convenience, flexibility, and timeliness of first contact for some patients, but these gains are unevenly distributed and depend heavily on system design, workflow integration, and patient capability. Evidence generated during the COVID-19 emergency should not be conflated with the evaluation of routine, policy-driven post-pandemic DFPC, because the goals, constraints, and patient expectations differ across these contexts. We therefore argue that DFPC aligns with PCC only when implemented within a flexible hybrid model that preserves modality choice, supports continuity, provides safe escalation to in-person care, and actively mitigates digital exclusion. Future research should prioritize patient-reported experience, continuity, safety, and equity outcomes under routine post-pandemic conditions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.